Stockreport

Lyra Therapeutics shares soar 32% in trading debut [MarketWatch]

Lyra Therapeutics, Inc.  (LYRA) 
PDF Shares of Lyra Therapeutics Inc. , a biotech specializing in treatments for ear, nose and throat diseases, soared 32% in their trading debut Friday, after the company's [Read more]